Global Gamma Knife Market

Gamma Knife Comprehensive Study by Application (Hospitals, Emergency Departments, Others), Treatment Type (Brain Metastasis, Cancer, Trigeminal Neuralgia, Others) Players and Region - Global Market Outlook to 2027

Gamma Knife Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Gamma Knife Market Scope
Gamma Knife is a computer-guided treatment that delivers highly focused radiation to tumors and lesions in the brain with very high precision. A treatment consisting of a radiation oncologist, a medical physicist, and a neurosurgeon will work together to provide your treatment. In Gamma Knife, there is an array of separate cobalt sources which number 192 in the Perfexion Model of the Gamma Knife, and each of these produces a fine beam of gamma radiation.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledElekta Instrument Ab (Sweden), Pacific Star International (China), Elekta Inc. (United States), Combimar & Agemar SpA (Italy), Transocean Shipping Transp. Ges.Mbh (Austria), Shine International Transportation (China), Austromar S.R.O. (Czech Republic), New Lines Co., Ltd. (Thailand), Seatrade International Transportati (China) and Transglory S.A. (France)
CAGR%


The companies are trying to innovate most advanced system will offer significantly faster automated treatment planning for clinicians.The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.

Elekta Instrument Ab (Sweden), Pacific Star International (China), Elekta Inc. (United States), Combimar & Agemar SpA (Italy), Transocean Shipping Transp. Ges.Mbh (Austria), Shine International Transportation (China), Austromar S.R.O. (Czech Republic), New Lines Co., Ltd. (Thailand), Seatrade International Transportati (China) and Transglory S.A. (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Elekta Instrument Ab (Sweden) and Pacific Star International (China).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Gamma Knife market by Type , by Application (Hospitals, Emergency Departments and Others) and Region with country level break-up.

On the basis of geography, the market of Gamma Knife has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

Market Leaders and their expansionary development strategies
On 18th June 2020, American Shared Hospital Services "AMS" a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced that its 81% owned subsidiary, GK Financing, LLC “GKF” has completed the acquisition of approximately 98% of the total outstanding shares of Gamma Knife Center Ecuador S.A. (“GKC Ecuador”) purchased from GKC Ecuador's majority shareholders Global Medical Investments GMI AB, Scandinavian Care Investments AB, and Brock Investment Limited the "Acquisition”. At a later date, AMS plans to acquire the remaining outstanding shares of GKC Ecuador by entering into a separate stock purchase agreement with the remaining minority shareholders of GKC Ecuador.
On 6th May 2022, Elekta has evolved radiosurgery to an unprecedented level with the launch of Elekta Esprit. This latest and most advanced system will offer significantly faster automated treatment planning for clinicians, more personalized and patient-friendly treatments, and a degree of precision able to protect the mind and the person. Esprit will allow clinicians to take radiosurgery to the next level and treat patients with the highest accuracy, protecting their mind and memories and enabling a higher quality of life says Gustaf Salford, Elekta’s President and CEO. Continuing the Leksell Gamma Knife tradition, Elekta yet again redefines what was thought possible in stereotactic radiosurgery.


Gamma Knife Market Dynamics:
AttributesDetails
Trends Influencing Market
  • Technological Improvements in Trigeminal Neuralgia Desis
  • Rapid Adoption of Advanced Technology 3D-printed headrest
Key Restraints
  • Availability of Alternative Technologies
Challenges
  • Lack of availability of Gamma Knife in some Rural Areas Can Create Challenges
Market Opportunities
  • Growing Technologies and New Developments in Gamma Knife with Unique Properties
  • Demand for Safety Monitoring to Avoid Harmful Effects of Surgery


Key Target Audience
Gamma knife Manufacturers, New Entrants, Research and Development Institutes and Others

Report Objectives / Segmentation Covered

By Application
  • Hospitals
  • Emergency Departments
  • Others
By Treatment Type
  • Brain Metastasis
  • Cancer
  • Trigeminal Neuralgia
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Advance treatment Innovative Gamma Knife Components to Improve Performance in treatment
      • 3.2.2. Increasing Demand for Gamma Knife radiosurgery system
    • 3.3. Market Challenges
      • 3.3.1. Lack of availability of Gamma Knife in some Rural Areas Can Create Challenges
    • 3.4. Market Trends
      • 3.4.1. Technological Improvements in Trigeminal Neuralgia Desis
      • 3.4.2. Rapid Adoption of Advanced Technology 3D-printed headrest
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Gamma Knife, by Application, Treatment Type and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Gamma Knife (Value)
      • 5.2.1. Global Gamma Knife by: Application (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Emergency Departments
        • 5.2.1.3. Others
      • 5.2.2. Global Gamma Knife by: Treatment Type (Value)
        • 5.2.2.1. Brain Metastasis
        • 5.2.2.2. Cancer
        • 5.2.2.3. Trigeminal Neuralgia
        • 5.2.2.4. Others
      • 5.2.3. Global Gamma Knife Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Australia
          • 5.2.3.2.6. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Gamma Knife (Price)
  • 6. Gamma Knife: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Elekta Instrument Ab (Sweden)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pacific Star International (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elekta Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Combimar & Agemar SpA (Italy)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Transocean Shipping Transp. Ges.Mbh (Austria)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Shine International Transportation (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Austromar S.R.O. (Czech Republic)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. New Lines Co., Ltd. (Thailand)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Seatrade International Transportati (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Transglory S.A. (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Gamma Knife Sale, by Application, Treatment Type and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Gamma Knife (Value)
      • 7.2.1. Global Gamma Knife by: Application (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Emergency Departments
        • 7.2.1.3. Others
      • 7.2.2. Global Gamma Knife by: Treatment Type (Value)
        • 7.2.2.1. Brain Metastasis
        • 7.2.2.2. Cancer
        • 7.2.2.3. Trigeminal Neuralgia
        • 7.2.2.4. Others
      • 7.2.3. Global Gamma Knife Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Australia
          • 7.2.3.2.6. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Gamma Knife (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Gamma Knife: by Application(USD Million)
  • Table 2. Gamma Knife Hospitals , by Region USD Million (2016-2021)
  • Table 3. Gamma Knife Emergency Departments , by Region USD Million (2016-2021)
  • Table 4. Gamma Knife Others , by Region USD Million (2016-2021)
  • Table 5. Gamma Knife: by Treatment Type(USD Million)
  • Table 6. Gamma Knife Brain Metastasis , by Region USD Million (2016-2021)
  • Table 7. Gamma Knife Cancer , by Region USD Million (2016-2021)
  • Table 8. Gamma Knife Trigeminal Neuralgia , by Region USD Million (2016-2021)
  • Table 9. Gamma Knife Others , by Region USD Million (2016-2021)
  • Table 10. South America Gamma Knife, by Country USD Million (2016-2021)
  • Table 11. South America Gamma Knife, by Application USD Million (2016-2021)
  • Table 12. South America Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 13. Brazil Gamma Knife, by Application USD Million (2016-2021)
  • Table 14. Brazil Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 15. Argentina Gamma Knife, by Application USD Million (2016-2021)
  • Table 16. Argentina Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 17. Rest of South America Gamma Knife, by Application USD Million (2016-2021)
  • Table 18. Rest of South America Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 19. Asia Pacific Gamma Knife, by Country USD Million (2016-2021)
  • Table 20. Asia Pacific Gamma Knife, by Application USD Million (2016-2021)
  • Table 21. Asia Pacific Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 22. China Gamma Knife, by Application USD Million (2016-2021)
  • Table 23. China Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 24. Japan Gamma Knife, by Application USD Million (2016-2021)
  • Table 25. Japan Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 26. India Gamma Knife, by Application USD Million (2016-2021)
  • Table 27. India Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 28. South Korea Gamma Knife, by Application USD Million (2016-2021)
  • Table 29. South Korea Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 30. Australia Gamma Knife, by Application USD Million (2016-2021)
  • Table 31. Australia Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 32. Rest of Asia-Pacific Gamma Knife, by Application USD Million (2016-2021)
  • Table 33. Rest of Asia-Pacific Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 34. Europe Gamma Knife, by Country USD Million (2016-2021)
  • Table 35. Europe Gamma Knife, by Application USD Million (2016-2021)
  • Table 36. Europe Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 37. Germany Gamma Knife, by Application USD Million (2016-2021)
  • Table 38. Germany Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 39. France Gamma Knife, by Application USD Million (2016-2021)
  • Table 40. France Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 41. Italy Gamma Knife, by Application USD Million (2016-2021)
  • Table 42. Italy Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 43. United Kingdom Gamma Knife, by Application USD Million (2016-2021)
  • Table 44. United Kingdom Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 45. Netherlands Gamma Knife, by Application USD Million (2016-2021)
  • Table 46. Netherlands Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 47. Rest of Europe Gamma Knife, by Application USD Million (2016-2021)
  • Table 48. Rest of Europe Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 49. MEA Gamma Knife, by Country USD Million (2016-2021)
  • Table 50. MEA Gamma Knife, by Application USD Million (2016-2021)
  • Table 51. MEA Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 52. Middle East Gamma Knife, by Application USD Million (2016-2021)
  • Table 53. Middle East Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 54. Africa Gamma Knife, by Application USD Million (2016-2021)
  • Table 55. Africa Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 56. North America Gamma Knife, by Country USD Million (2016-2021)
  • Table 57. North America Gamma Knife, by Application USD Million (2016-2021)
  • Table 58. North America Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 59. United States Gamma Knife, by Application USD Million (2016-2021)
  • Table 60. United States Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 61. Canada Gamma Knife, by Application USD Million (2016-2021)
  • Table 62. Canada Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 63. Mexico Gamma Knife, by Application USD Million (2016-2021)
  • Table 64. Mexico Gamma Knife, by Treatment Type USD Million (2016-2021)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Gamma Knife: by Application(USD Million)
  • Table 76. Gamma Knife Hospitals , by Region USD Million (2022-2027)
  • Table 77. Gamma Knife Emergency Departments , by Region USD Million (2022-2027)
  • Table 78. Gamma Knife Others , by Region USD Million (2022-2027)
  • Table 79. Gamma Knife: by Treatment Type(USD Million)
  • Table 80. Gamma Knife Brain Metastasis , by Region USD Million (2022-2027)
  • Table 81. Gamma Knife Cancer , by Region USD Million (2022-2027)
  • Table 82. Gamma Knife Trigeminal Neuralgia , by Region USD Million (2022-2027)
  • Table 83. Gamma Knife Others , by Region USD Million (2022-2027)
  • Table 84. South America Gamma Knife, by Country USD Million (2022-2027)
  • Table 85. South America Gamma Knife, by Application USD Million (2022-2027)
  • Table 86. South America Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 87. Brazil Gamma Knife, by Application USD Million (2022-2027)
  • Table 88. Brazil Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 89. Argentina Gamma Knife, by Application USD Million (2022-2027)
  • Table 90. Argentina Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 91. Rest of South America Gamma Knife, by Application USD Million (2022-2027)
  • Table 92. Rest of South America Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 93. Asia Pacific Gamma Knife, by Country USD Million (2022-2027)
  • Table 94. Asia Pacific Gamma Knife, by Application USD Million (2022-2027)
  • Table 95. Asia Pacific Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 96. China Gamma Knife, by Application USD Million (2022-2027)
  • Table 97. China Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 98. Japan Gamma Knife, by Application USD Million (2022-2027)
  • Table 99. Japan Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 100. India Gamma Knife, by Application USD Million (2022-2027)
  • Table 101. India Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 102. South Korea Gamma Knife, by Application USD Million (2022-2027)
  • Table 103. South Korea Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 104. Australia Gamma Knife, by Application USD Million (2022-2027)
  • Table 105. Australia Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 106. Rest of Asia-Pacific Gamma Knife, by Application USD Million (2022-2027)
  • Table 107. Rest of Asia-Pacific Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 108. Europe Gamma Knife, by Country USD Million (2022-2027)
  • Table 109. Europe Gamma Knife, by Application USD Million (2022-2027)
  • Table 110. Europe Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 111. Germany Gamma Knife, by Application USD Million (2022-2027)
  • Table 112. Germany Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 113. France Gamma Knife, by Application USD Million (2022-2027)
  • Table 114. France Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 115. Italy Gamma Knife, by Application USD Million (2022-2027)
  • Table 116. Italy Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 117. United Kingdom Gamma Knife, by Application USD Million (2022-2027)
  • Table 118. United Kingdom Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 119. Netherlands Gamma Knife, by Application USD Million (2022-2027)
  • Table 120. Netherlands Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 121. Rest of Europe Gamma Knife, by Application USD Million (2022-2027)
  • Table 122. Rest of Europe Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 123. MEA Gamma Knife, by Country USD Million (2022-2027)
  • Table 124. MEA Gamma Knife, by Application USD Million (2022-2027)
  • Table 125. MEA Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 126. Middle East Gamma Knife, by Application USD Million (2022-2027)
  • Table 127. Middle East Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 128. Africa Gamma Knife, by Application USD Million (2022-2027)
  • Table 129. Africa Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 130. North America Gamma Knife, by Country USD Million (2022-2027)
  • Table 131. North America Gamma Knife, by Application USD Million (2022-2027)
  • Table 132. North America Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 133. United States Gamma Knife, by Application USD Million (2022-2027)
  • Table 134. United States Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 135. Canada Gamma Knife, by Application USD Million (2022-2027)
  • Table 136. Canada Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 137. Mexico Gamma Knife, by Application USD Million (2022-2027)
  • Table 138. Mexico Gamma Knife, by Treatment Type USD Million (2022-2027)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Gamma Knife: by Application USD Million (2016-2021)
  • Figure 5. Global Gamma Knife: by Treatment Type USD Million (2016-2021)
  • Figure 6. South America Gamma Knife Share (%), by Country
  • Figure 7. Asia Pacific Gamma Knife Share (%), by Country
  • Figure 8. Europe Gamma Knife Share (%), by Country
  • Figure 9. MEA Gamma Knife Share (%), by Country
  • Figure 10. North America Gamma Knife Share (%), by Country
  • Figure 11. Global Gamma Knife share by Players 2021 (%)
  • Figure 12. Global Gamma Knife share by Players (Top 3) 2021(%)
  • Figure 13. Global Gamma Knife share by Players (Top 5) 2021(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Elekta Instrument Ab (Sweden) Revenue, Net Income and Gross profit
  • Figure 16. Elekta Instrument Ab (Sweden) Revenue: by Geography 2021
  • Figure 17. Pacific Star International (China) Revenue, Net Income and Gross profit
  • Figure 18. Pacific Star International (China) Revenue: by Geography 2021
  • Figure 19. Elekta Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Elekta Inc. (United States) Revenue: by Geography 2021
  • Figure 21. Combimar & Agemar SpA (Italy) Revenue, Net Income and Gross profit
  • Figure 22. Combimar & Agemar SpA (Italy) Revenue: by Geography 2021
  • Figure 23. Transocean Shipping Transp. Ges.Mbh (Austria) Revenue, Net Income and Gross profit
  • Figure 24. Transocean Shipping Transp. Ges.Mbh (Austria) Revenue: by Geography 2021
  • Figure 25. Shine International Transportation (China) Revenue, Net Income and Gross profit
  • Figure 26. Shine International Transportation (China) Revenue: by Geography 2021
  • Figure 27. Austromar S.R.O. (Czech Republic) Revenue, Net Income and Gross profit
  • Figure 28. Austromar S.R.O. (Czech Republic) Revenue: by Geography 2021
  • Figure 29. New Lines Co., Ltd. (Thailand) Revenue, Net Income and Gross profit
  • Figure 30. New Lines Co., Ltd. (Thailand) Revenue: by Geography 2021
  • Figure 31. Seatrade International Transportati (China) Revenue, Net Income and Gross profit
  • Figure 32. Seatrade International Transportati (China) Revenue: by Geography 2021
  • Figure 33. Transglory S.A. (France) Revenue, Net Income and Gross profit
  • Figure 34. Transglory S.A. (France) Revenue: by Geography 2021
  • Figure 35. Global Gamma Knife: by Application USD Million (2022-2027)
  • Figure 36. Global Gamma Knife: by Treatment Type USD Million (2022-2027)
  • Figure 37. South America Gamma Knife Share (%), by Country
  • Figure 38. Asia Pacific Gamma Knife Share (%), by Country
  • Figure 39. Europe Gamma Knife Share (%), by Country
  • Figure 40. MEA Gamma Knife Share (%), by Country
  • Figure 41. North America Gamma Knife Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Elekta Instrument Ab (Sweden)
  • Pacific Star International (China)
  • Elekta Inc. (United States)
  • Combimar & Agemar SpA (Italy)
  • Transocean Shipping Transp. Ges.Mbh (Austria)
  • Shine International Transportation (China)
  • Austromar S.R.O. (Czech Republic)
  • New Lines Co., Ltd. (Thailand)
  • Seatrade International Transportati (China)
  • Transglory S.A. (France)
Additional players considered in the study are as follows:
Elekta Instrument Ab (Sweden) , Pacific Star International (China)
Select User Access Type

Key Highlights of Report


Aug 2022 230 Pages 81 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Gamma Knife Market Quantitative research analysis
Global Gamma Knife Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Gamma Knife Market are by end use application [Hospitals, Emergency Departments and Others].
The Gamma Knife Market is gaining popularity and expected to see strong valuation by 2027.
  • Growing Demand for Advance treatment Innovative Gamma Knife Components to Improve Performance in treatment
  • Increasing Demand for Gamma Knife radiosurgery system

Know More About Global Gamma Knife Market Report?

Have a Query? Click Here

Other Related Reports

Chabots in Healthcare Comprehensive Study by Application (Collecting Patient Data, Providing Assistance, Schedule Appointments, Symptom Check), End User (Patient, Insurance Companies, Healthcare Pro...
$ 3800
Antibody Development Services Comprehensive Study by Type (Antibody Development, Antigen Preparation, Immunization Production, Antibody Characterization, Antibody Production, Antibody Purification, A...
$ 3800
Sex Hormones- Comprehensive Study by Type (Progesterone, Testosterone, Drospirenone), Application (Topical, Inhalation, Injection, Others) Players and Region - Global Market Outlook to 2027
$ 3800
Machine Learning in Healthcare- Comprehensive Study by Type (Software Solutions, Hardware, Services), Application (Robot-Assisted Surgery, Virtual Assistants, Administrative Workflow Assistants, Conn...
$ 3800
Electroanatomical Cardiac Mapping Comprehensive Study by Type (Contact Cardiac, Non-Contact Cardiac), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT, Other) Players and Region - Global Market...
$ 3800
Intelligent Hospital System - Comprehensive Study by Type (Appointment Management, Patient Management, Facility Management, Staff Management, Supply Management, Others), Application (Hospitals, Clini...
$ 3800